Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 19 | 2024 | 1046 | 2.580 |
Why?
|
| Shock, Cardiogenic | 3 | 2024 | 192 | 2.140 |
Why?
|
| Heart Failure | 24 | 2023 | 2154 | 2.060 |
Why?
|
| Ventricular Function, Left | 10 | 2020 | 495 | 1.580 |
Why?
|
| Myocardium | 9 | 2019 | 997 | 1.390 |
Why?
|
| Heart Ventricles | 9 | 2018 | 770 | 1.080 |
Why?
|
| Myocardial Ischemia | 6 | 2019 | 337 | 1.010 |
Why?
|
| Cytokines | 2 | 2021 | 1279 | 0.970 |
Why?
|
| Cardiomyopathies | 5 | 2019 | 479 | 0.970 |
Why?
|
| Proteome | 2 | 2024 | 241 | 0.940 |
Why?
|
| Recovery of Function | 5 | 2017 | 440 | 0.880 |
Why?
|
| Inflammation Mediators | 1 | 2024 | 235 | 0.800 |
Why?
|
| Biomarkers | 5 | 2024 | 2980 | 0.770 |
Why?
|
| Hemodynamics | 4 | 2024 | 844 | 0.720 |
Why?
|
| Oxygenators, Membrane | 1 | 2020 | 8 | 0.720 |
Why?
|
| Proteomics | 1 | 2024 | 491 | 0.690 |
Why?
|
| Inflammation | 3 | 2024 | 1414 | 0.670 |
Why?
|
| Lymphocytes | 1 | 2020 | 406 | 0.620 |
Why?
|
| Neutrophils | 1 | 2020 | 378 | 0.600 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2024 | 627 | 0.550 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2015 | 146 | 0.540 |
Why?
|
| Diastole | 2 | 2015 | 167 | 0.490 |
Why?
|
| Ventricular Remodeling | 4 | 2020 | 174 | 0.480 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2015 | 360 | 0.470 |
Why?
|
| Coronary Circulation | 4 | 2015 | 211 | 0.350 |
Why?
|
| Middle Aged | 22 | 2024 | 26459 | 0.310 |
Why?
|
| Time Factors | 9 | 2024 | 6272 | 0.300 |
Why?
|
| Myocardial Contraction | 4 | 2017 | 262 | 0.280 |
Why?
|
| RNA | 2 | 2023 | 568 | 0.260 |
Why?
|
| Heart Transplantation | 3 | 2021 | 857 | 0.250 |
Why?
|
| Mitochondria, Heart | 2 | 2016 | 60 | 0.240 |
Why?
|
| Male | 24 | 2024 | 61025 | 0.230 |
Why?
|
| No-Reflow Phenomenon | 2 | 2015 | 9 | 0.230 |
Why?
|
| Humans | 33 | 2024 | 124398 | 0.230 |
Why?
|
| Myocytes, Cardiac | 3 | 2020 | 622 | 0.220 |
Why?
|
| Blood Proteins | 1 | 2024 | 116 | 0.220 |
Why?
|
| Aged | 12 | 2024 | 19479 | 0.210 |
Why?
|
| Coronary Vessels | 2 | 2019 | 537 | 0.210 |
Why?
|
| Cardiomegaly | 2 | 2020 | 131 | 0.210 |
Why?
|
| Female | 21 | 2024 | 66305 | 0.200 |
Why?
|
| Treatment Outcome | 8 | 2024 | 12287 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2017 | 6089 | 0.190 |
Why?
|
| Tuberculosis, Miliary | 1 | 2021 | 10 | 0.190 |
Why?
|
| Prognosis | 4 | 2021 | 4554 | 0.180 |
Why?
|
| Interleukin-6 | 1 | 2023 | 415 | 0.180 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 31 | 0.180 |
Why?
|
| Anion Transport Proteins | 1 | 2020 | 30 | 0.180 |
Why?
|
| Echocardiography | 5 | 2019 | 1052 | 0.180 |
Why?
|
| Lymphocyte Count | 1 | 2020 | 117 | 0.180 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 60 | 0.170 |
Why?
|
| Heart, Artificial | 1 | 2020 | 68 | 0.170 |
Why?
|
| Prosthesis Design | 2 | 2020 | 688 | 0.170 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2020 | 78 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 152 | 0.160 |
Why?
|
| Interferon-gamma | 1 | 2021 | 502 | 0.160 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 672 | 0.150 |
Why?
|
| Machine Learning | 1 | 2021 | 242 | 0.150 |
Why?
|
| Vasodilation | 1 | 2019 | 189 | 0.150 |
Why?
|
| Cardiology | 1 | 2023 | 478 | 0.150 |
Why?
|
| Hematologic Neoplasms | 1 | 2021 | 286 | 0.150 |
Why?
|
| Muscle Proteins | 1 | 2020 | 418 | 0.140 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 5107 | 0.140 |
Why?
|
| Apoptosis | 1 | 2024 | 1789 | 0.140 |
Why?
|
| Excitation Contraction Coupling | 1 | 2017 | 11 | 0.140 |
Why?
|
| Atrial Appendage | 1 | 2017 | 46 | 0.140 |
Why?
|
| Microscopy, Confocal | 2 | 2017 | 348 | 0.140 |
Why?
|
| Swine | 3 | 2015 | 1173 | 0.140 |
Why?
|
| Cardiovascular Agents | 1 | 2017 | 86 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 1011 | 0.130 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 515 | 0.130 |
Why?
|
| Myocardial Reperfusion | 1 | 2015 | 72 | 0.130 |
Why?
|
| Hospital Mortality | 1 | 2020 | 1020 | 0.120 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2122 | 0.120 |
Why?
|
| Arterial Pressure | 1 | 2015 | 101 | 0.120 |
Why?
|
| Dabigatran | 1 | 2015 | 27 | 0.120 |
Why?
|
| Insulin | 1 | 2020 | 1207 | 0.120 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2014 | 44 | 0.120 |
Why?
|
| Cell Respiration | 1 | 2014 | 24 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 2896 | 0.120 |
Why?
|
| Mitochondria, Muscle | 1 | 2014 | 35 | 0.110 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 395 | 0.110 |
Why?
|
| Thromboembolism | 1 | 2015 | 88 | 0.110 |
Why?
|
| Atrophy | 1 | 2014 | 236 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 135 | 0.110 |
Why?
|
| Ubiquitin | 1 | 2014 | 142 | 0.110 |
Why?
|
| Adult | 8 | 2024 | 29396 | 0.110 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2014 | 213 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2020 | 3382 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2012 | 59 | 0.100 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 238 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 510 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 1111 | 0.100 |
Why?
|
| Blotting, Western | 1 | 2014 | 1108 | 0.100 |
Why?
|
| Heart Failure, Diastolic | 1 | 2012 | 10 | 0.100 |
Why?
|
| Aorta | 1 | 2015 | 541 | 0.100 |
Why?
|
| Hyperparathyroidism, Secondary | 1 | 2012 | 14 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2018 | 1002 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 862 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2015 | 463 | 0.090 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2011 | 16 | 0.090 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 436 | 0.090 |
Why?
|
| Stroke Volume | 4 | 2016 | 449 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2012 | 116 | 0.090 |
Why?
|
| Resistance Training | 1 | 2011 | 32 | 0.090 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 951 | 0.090 |
Why?
|
| Animals | 9 | 2020 | 34139 | 0.090 |
Why?
|
| Muscle Weakness | 1 | 2011 | 84 | 0.090 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 63 | 0.080 |
Why?
|
| Heart | 2 | 2016 | 718 | 0.080 |
Why?
|
| Bone Density | 1 | 2012 | 319 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2014 | 778 | 0.080 |
Why?
|
| Biopsy | 3 | 2019 | 1237 | 0.080 |
Why?
|
| Heart Rate | 1 | 2011 | 588 | 0.080 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 755 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 554 | 0.070 |
Why?
|
| Models, Genetic | 1 | 2011 | 759 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 10149 | 0.070 |
Why?
|
| Electrocardiography | 1 | 2011 | 968 | 0.060 |
Why?
|
| Models, Cardiovascular | 2 | 2018 | 180 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2020 | 16234 | 0.060 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2023 | 13 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2023 | 74 | 0.050 |
Why?
|
| Endothelium | 1 | 2023 | 72 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2015 | 3068 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2020 | 3753 | 0.050 |
Why?
|
| Pyrazinamide | 1 | 2021 | 12 | 0.050 |
Why?
|
| Isoniazid | 1 | 2021 | 62 | 0.050 |
Why?
|
| Absorptiometry, Photon | 2 | 2012 | 178 | 0.050 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2020 | 50 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2020 | 36 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 315 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 147 | 0.040 |
Why?
|
| Exercise Test | 2 | 2011 | 248 | 0.040 |
Why?
|
| Oxygen Consumption | 2 | 2012 | 306 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2020 | 68 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2023 | 683 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 525 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2021 | 247 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 503 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2023 | 1085 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 670 | 0.040 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2018 | 65 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2018 | 109 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 492 | 0.040 |
Why?
|
| Periodicity | 1 | 2017 | 55 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2017 | 3268 | 0.040 |
Why?
|
| Mutation | 1 | 2011 | 5809 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2020 | 488 | 0.040 |
Why?
|
| CpG Islands | 1 | 2018 | 323 | 0.030 |
Why?
|
| Mice | 3 | 2020 | 17725 | 0.030 |
Why?
|
| Free Radicals | 1 | 2016 | 31 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2021 | 1174 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 375 | 0.030 |
Why?
|
| Mitochondria | 1 | 2020 | 689 | 0.030 |
Why?
|
| Ligation | 1 | 2015 | 135 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 93 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 125 | 0.030 |
Why?
|
| Greece | 1 | 2015 | 11 | 0.030 |
Why?
|
| Vascular Resistance | 1 | 2015 | 186 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2020 | 643 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1392 | 0.030 |
Why?
|
| Electron Transport Complex II | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2017 | 235 | 0.030 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 19 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 122 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2014 | 32 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 1612 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 96 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 580 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 107 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 675 | 0.030 |
Why?
|
| Cardiac Catheterization | 1 | 2017 | 632 | 0.030 |
Why?
|
| Collagen | 1 | 2014 | 314 | 0.030 |
Why?
|
| Cell Line | 1 | 2018 | 2770 | 0.030 |
Why?
|
| Phenotype | 2 | 2014 | 4255 | 0.030 |
Why?
|
| Systole | 1 | 2013 | 195 | 0.030 |
Why?
|
| Fibrosis | 1 | 2014 | 432 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1272 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2012 | 72 | 0.020 |
Why?
|
| Rats | 1 | 2018 | 3687 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4425 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 643 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 1695 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 1273 | 0.020 |
Why?
|
| KRIT1 Protein | 1 | 2011 | 1 | 0.020 |
Why?
|
| Health Status Indicators | 1 | 2012 | 120 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2012 | 279 | 0.020 |
Why?
|
| Anaerobic Threshold | 1 | 2011 | 11 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2012 | 254 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 426 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 124 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2012 | 150 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2011 | 75 | 0.020 |
Why?
|
| Vitamin D | 1 | 2012 | 159 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2011 | 150 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2011 | 79 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2011 | 142 | 0.020 |
Why?
|
| 3-Iodobenzylguanidine | 1 | 2010 | 12 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2010 | 43 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2010 | 50 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 586 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 246 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2012 | 578 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 160 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2011 | 274 | 0.020 |
Why?
|
| Sodium | 1 | 2010 | 294 | 0.020 |
Why?
|
| Young Adult | 2 | 2014 | 8979 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2013 | 928 | 0.020 |
Why?
|
| Creatinine | 1 | 2010 | 382 | 0.020 |
Why?
|
| Body Composition | 1 | 2011 | 524 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 549 | 0.020 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2010 | 276 | 0.020 |
Why?
|
| Incidence | 1 | 2015 | 3086 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 1186 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2011 | 1000 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2042 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 2408 | 0.020 |
Why?
|
| United States | 1 | 2020 | 10773 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4355 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2552 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 821 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 3003 | 0.010 |
Why?
|